Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Haderselv, K"'
Autor:
Attauabi, M, Hoglund, C, Fassov, J, Pedersen, K B, Hansen, H Bansholm, Wildt, S, Jensen, M Dam, Neumann, A, Lind, C, Jacobsen, H Albaek, Popa, A M, Kjeldsen, J, Pedersen, N, Molazahi, A, Haderselv, K, Aalykke, C, Knudsen, T, Cebula, W, Munkholm, P, Bendtsen, F, Seidelin, J B, Johan, B
Publikováno v:
Attauabi, M, Höglund, C, Fassov, J, Bo Pedersen, K, Hansen, H B, Wildt, S, Dam Jensen, M, Neumann, A, Lind, C, Jacobsen, H A, Popa, A M, Kjeldsen, J, Pedersen, N, Molazahi, A, Haderselv, K, Aalykke, C, Knudsen, T, Cebula, W, Munkholm, P, Bendtsen, F, Seidelin, J B & Johan, B 2021, ' Vedolizumab as first line biologic therapy in elderly patients with contraindications against anti-TNF therapy-A real-world nationwide cohort of patients with inflammatory bowel diseases ', Journal of Crohn's and Colitis, vol. 15, no. Suppl. 1, P347, pp. S369–S370 . https://doi.org/10.1093/ecco-jcc/jjab076.471
Attauabi, M, Hoglund, C, Fassov, J, Pedersen, K B, Hansen, H B, Wildt, S, Jensen, M D, Neumann, A, Lind, C, Jacobsen, H A, Popa, A M, Kjeldsen, J, Pedersen, N, Molazahi, A, Haderselv, K, Aalykke, C, Knudsen, T, Cebula, W, Munkholm, P, Bendtsen, F, Seidelin, J B & Johan, B 2021, ' Vedolizumab as first line biologic therapy in elderly patients with contraindications against anti-TNF therapy-A real-world nationwide cohort of patients with inflammatory bowel diseases ', Journal of Crohn's & colitis, vol. 15, no. Suppl. 1, pp. S369-S370 . https://doi.org/10.1093/ecco-jcc/jjab076.471
Attauabi, M, Hoglund, C, Fassov, J, Pedersen, K B, Hansen, H B, Wildt, S, Jensen, M D, Neumann, A, Lind, C, Jacobsen, H A, Popa, A M, Kjeldsen, J, Pedersen, N, Molazahi, A, Haderselv, K, Aalykke, C, Knudsen, T, Cebula, W, Munkholm, P, Bendtsen, F, Seidelin, J B & Johan, B 2021, ' Vedolizumab as first line biologic therapy in elderly patients with contraindications against anti-TNF therapy-A real-world nationwide cohort of patients with inflammatory bowel diseases ', Journal of Crohn's & colitis, vol. 15, no. Suppl. 1, pp. S369-S370 . https://doi.org/10.1093/ecco-jcc/jjab076.471
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::c11e9ac186de1aa9d1bd72008019a413
https://portal.findresearcher.sdu.dk/da/publications/9f2725ba-6ae4-43ec-aa60-2f50f5f38ab1
https://portal.findresearcher.sdu.dk/da/publications/9f2725ba-6ae4-43ec-aa60-2f50f5f38ab1
Autor:
Attauabi, M, Poulsen, A, Verner-Andersen, M Kajbaek, Hansen, M Rosager, Pedersen, N, Prahm, A Pilegaard, Lødrup, A Berg, Haderselv, K, Larsen, L, Jess, T, Glerup, H, Molazahi, A, Oppfeldt, A Mathiassen, Dahlerup, J F, Hvas, C Lodberg, Neumann, A, Wase, A, Jensen, M Dam, Nathan, T, Jensen, S, Theede, K, Kiszka-Kanowitz, M, Seidelin, J Benedict, Burisch, J
Publikováno v:
Attauabi, M, Poulsen, A, Verner-Andersen, M K, Hansen, M R, Pedersen, N, Prahm, A P, Lødrup, A B, Haderselv, K, Larsen, L, Jess, T, Glerup, H, Molazahi, A, Oppfeldt, A M, Dahlerup, J F, Hvas, C L, Neumann, A, Wase, A, Jensen, M D, Nathan, T, Jensen, S, Theede, K, Kiszka-Kanowitz, M, Seidelin, J B, Burisch, J & the Danish COVID-IBD Study Group 2021, ' Outcomes of coronavirus disease 2019 among patients with inflammatory bowel diseases and the influence of IBD-related medications-A Danish prospective population-based cohort study ', Journal of Crohn's & colitis, vol. 15, no. Suppl. 1, pp. S197-S197 . https://doi.org/10.1093/ecco-jcc/jjab076.230
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::a130c03bf4290b72665109a68b373686
https://vbn.aau.dk/da/publications/b217c787-04e2-461d-86ce-9ecf89cd398a
https://vbn.aau.dk/da/publications/b217c787-04e2-461d-86ce-9ecf89cd398a
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.